Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Neoplasma|January 1, 1979
Histologic changes in the human skin melanoma after intratumorous treatment with BCGJ Svejda, Z Mechl, B Sopková, et al.Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|January 11, 2013
[A case report: patient with advanced ovarial tumour and supporting care]D Brančíková, L Ostřížková, M Protivánková, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1988
Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II studyK Kolarić, V Potrebica, D Vukas, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
HLA-DR antigen expression on melanoma metastases and the course of the diseaseM Munzarová, D Zemanová, A Rejthar, et al.Neoplasma|January 1, 1987
The excretion of urinary enzymes, proteins and creatinine in patients receiving cisplatinumM Nekulová, Z Mechl, S Kerpel-Fronius, et al.Journal of Clinical Pathology|October 1, 1988
DNA content and MHC class II antigen expression in malignant melanoma: clinical courseJ Zaloudik, M Moore, A K Ghosh, et al.Neoplasma|January 1, 1979
Comparison of the excretion of different types of melanogens in the melanoma patientsB Matous, S Pavel, A Budĕsínská, et al.Current Oncology (Toronto, Ont.)|June 20, 2015
Patient with inoperable pheochromocytomaD Brancíková, Z Mechl, Z Adam, et al.Neoplasma|January 1, 1993
Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphomaJ G Patel, R Pandita, H al-Jazzaf, et al.Zentralblatt Fur Gynakologie|January 1, 1984
[Experiences with cisplatin (Platidiam) chemotherapy in secondary resistant ovarian carcinomas]W Krafft, Z Mechl, H Behling, et al.Pageof 5